EC Pharmacology and Toxicology

According to a recent publication in BioMed Research International, malaria can be a significant public health issue in Ethiopia and elsewhere in Africa. Malaria currently looks to be increasing in a number of locations where it was previously under control, according to this paper written by Tekalign., et al [1]. Anopheles stephensi's emergence in Africa [1] and the influence of the COVID-19 pandemic on prevention and control efforts [2] were mentioned in the literature as contributing factors to this problem. Malaria is responsible for about 10% of all diseases in Africa. Nearly 70% of Ethiopia is affected, with 52% of the population at risk. Tekalign., et al. also discussed various difficulties with malaria preventive and treatment methods, such as partial resistance to artemisinin. Additionally, gaps in the novel therapeutic pipeline and prospective alternatives such medicinal plants were considered [1]. The goal of this remark was to further explain the impact of malaria, the challenges associated with its preventive, control, and treatment strategies, as well as to address recent events and potential future directions.

Keywords: Malaria; Ethiopia; Africa, Anopheles stephensi

1. Tekalign E., et al. “Suppressive, Curative, and Prophylactic Effects of Maesa lanceolata against Rodent Malaria Parasite Plasmodium berghei”. BioMed Research International 6 (2022): 1-18.
2. World Malaria Report. World Health Organization, Geneva, Switzerland (2021).
3. World Malaria Day. World Health Organization, Geneva, Switzerland (2022).
4. Kendie FA., et al. “Prevalence of Malaria among Adults in Ethiopia: A Systematic Review and Meta-Analysis”. Journal of Tropical Medicine (2021): 1-9.
5. “Clarification Statement Regarding Current Malaria Distributions in the country (In Amharic)”. Ethiopian Federal Ministry of Health, Addis Ababa, Ethiopia (2022).
6. Duguma T., et al. “Malaria prevalence and risk factors among patients visiting Mizan-Tepi University Teaching Hospital, Southwest Ethiopia”. PLoS ONE7 (2022): e0271771.
7. Bench-Sheko Zone Health Department. Four Month Malaria Report, Bench-Sheko Zone, Southwest Ethiopia (2022).
8. Negatu GA., et al. “Prevalence of Malaria and Associated Factors among Malaria-Suspected Patients Attending Hamusit Health Center, Northwest Ethiopia: A Cross-Sectional Study”. Journal of Parasitology Research (2022): 1-7.
9. Yalew AW. “Achievements, Gaps, and Emerging Challenges in Controlling Malaria in Ethiopia”. Frontiers in Tropical Diseases 2 (2022): 771030.
10. Hamlet A., et al. “The potential impact of Anopheles stephensi establishment on the transmission of Plasmodium falciparum in Ethiopia and prospective control measures”. BMC Medicine 20 (2022): 135.
11. Sinka ME., et al. “A new malaria vector in Africa: Predicting the expansion range of Anopheles stephensi and identifying the urban populations at risk”. Proceedings of the National Academy of Sciences of the United States of America40 (2020): 24900-24908.
12. Baragona S. “Invasive Mosquito Threatens Malaria Control in Africa”. Voanews (2022).
13. Balkew M., et al. “An update on the distribution, bionomics, and insecticide susceptibility of Anopheles stephensi in Ethiopia, 2018–2020”. Malar Journal 20 (2021): 263.
14. Yared S., et al. “Insecticide resistance in Anopheles stephensi in Somali Region, eastern Ethiopia”. Malaria Journal 19 (2020): 180.
15. Mnzava A., et al. “Anopheles stephensi in Africa requires a more integrated response”. Malaria Journal 21 (2022): 156.
16. Tackling emerging antimalarial drug resistance in Africa. World Health Organization, Geneva, Switzerland (2022).
17. Sema YA and Waktola TA. “Anti-malarial plants in Ethiopia and their activities on drug-resistant malaria”. FEMS Microbes 3 (2022): 1-5.
18. Deressa T., et al. “In vivo efficacy of artemether–lumefantrine against uncomplicated Plasmodium falciparum malaria in Dembia District, northwest Ethiopia”. Therapeutics and Clinical Risk Management 13 (2017): 201-206.
19. Heuchert A., et al. “Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013”. Malaria Journal 14 (2015): 208.
20. Hailemeskel E., et al. “Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia”. IJP: Drugs and Drug Resistance 11 (2019): 8-12.
21. Nureye D. “Malaria: Introductory Concepts, Resistance Issues and Current Medicines”. In: Plasmodium Species and Drug Resistance. Intech Open (2021).
22. Fongnikin A., et al. “Efficacy of Fludora^® Fusion (a mixture of deltamethrin and clothianidin) for indoor residual spraying against pyrethroid-resistant malaria vectors: laboratory and experimental hut evaluation”. Parasites Vectors 13 (2020): 466.
23. Hassan Vatandoost., et al. “Evaluation of (Fludora^® Fusion) (A Mixture of Deltamethrin and Clothianidin) For Indoor Residual Spraying Against Insecticide Resistant Strain of Anopheles Stephensi in A Malarious Area in Bandar Abbas, Iran”. Research Square (2021): 1-12.
24. New frontiers in vector control. World Health Organization, Geneva, Switzerland (2022).
25. This Discovery Of 29 ‘New’ Mosquito Genes Could Open Door to Curbing Malaria Spread In India. Tata Institute for Genetics and Society (2022).